Cancers (Sep 2019)

Epigenetic Regulation of p21<sup>cip1/waf1</sup> in Human Cancer

  • Matthias Ocker,
  • Samar Al Bitar,
  • Ana Carolina Monteiro,
  • Hala Gali-Muhtasib,
  • Regine Schneider-Stock

DOI
https://doi.org/10.3390/cancers11091343
Journal volume & issue
Vol. 11, no. 9
p. 1343

Abstract

Read online

p21cip1/waf1 is a central regulator of cell cycle control and survival. While mutations are rare, it is commonly dysregulated in several human cancers due to epigenetic mechanisms influencing its transcriptional control. These mechanisms include promoter hypermethylation as well as additional pathways such as histone acetylation or methylation. The epigenetic regulators include writers, such as DNA methyltransferases (DNMTs); histone acetyltransferases (HATs) and histone lysine methyltransferases; erasers, such as histone deacetylases (HDACs); histone lysine demethylases [e.g., the Lysine Demethylase (KDM) family]; DNA hydroxylases; readers, such as the methyl-CpG-binding proteins (MBPs); and bromodomain-containing proteins, including the bromo- and extraterminal domain (BET) family. We further discuss the roles that long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) play in the epigenetic control of p21cip1/waf1 expression and its function in human cancers.

Keywords